Ginkgo Bioworks Holdings (DNA) EBIAT: 2020-2025
Historic EBIAT for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -$80.8 million.
- Ginkgo Bioworks Holdings' EBIAT fell 43.18% to -$80.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$339.5 million, marking a year-over-year increase of 47.86%. This contributed to the annual value of -$547.0 million for FY2024, which is 38.73% up from last year.
- Per Ginkgo Bioworks Holdings' latest filing, its EBIAT stood at -$80.8 million for Q3 2025, which was down 33.92% from -$60.3 million recorded in Q2 2025.
- In the past 5 years, Ginkgo Bioworks Holdings' EBIAT registered a high of -$54.5 million during Q2 2021, and its lowest value of -$1.6 billion during Q4 2021.
- Its 3-year average for EBIAT is -$152.0 million, with a median of -$165.9 million in 2024.
- Its EBIAT has fluctuated over the past 5 years, first crashed by 3,359.12% in 2021, then soared by 89.22% in 2022.
- Over the past 5 years, Ginkgo Bioworks Holdings' EBIAT (Quarterly) stood at -$1.6 billion in 2021, then spiked by 89.22% to -$173.1 million in 2022, then decreased by 22.31% to -$211.7 million in 2023, then surged by 49.20% to -$107.5 million in 2024, then tumbled by 43.18% to -$80.8 million in 2025.
- Its EBIAT was -$80.8 million in Q3 2025, compared to -$60.3 million in Q2 2025 and -$91.0 million in Q1 2025.